U.S. Stock News

TETRA Technologies (TTI) has drawn fresh attention after a strong share price move over the past month and the past three months, prompting investors to reassess its valuation and recent financial profile. See our latest analysis for TETRA Technologies. That recent share price run, including a 21.66% 30 day share price return and 61.47% 90 day share price return to US$11.40, sits alongside a very strong 1 year total shareholder return of 174.70% and a 5 year total shareholder return above 4x...

Viavi Solutions (VIAV) has just posted Q2 2026 results with revenue of US$369.3 million and a basic EPS loss of US$0.21, while trailing twelve month figures show revenue of US$1.2 billion and a basic EPS loss of US$0.19. Over recent quarters, the company has seen revenue move from US$270.8 million in Q2 2025 to US$369.3 million in Q2 2026, with EPS shifting from a profit of US$0.04 to a loss of US$0.21 as margins compressed. See our full analysis for Viavi Solutions. With the latest numbers...

Silicom (SILC) closed FY 2025 with Q4 revenue of US$16.9 million and a basic EPS loss of US$0.44, alongside net income excluding extra items of a US$2.5 million loss, putting another loss-making quarter on the scoreboard. Over recent periods the company has seen quarterly revenue move from US$14.5 million in Q4 2024 through US$14.4 million in Q1 2025, US$15.0 million in Q2, and US$15.6 million in Q3. Quarterly basic EPS stayed in loss territory, ranging from a US$1.05 loss per share in Q4...

Vera Therapeutics (NasdaqGM:VERA) has appointed Matt Skelton as Chief Commercial Officer. The move comes as the company prepares for potential commercialization of its lead drug, atacicept, for IgA nephropathy. Atacicept has received Breakthrough Therapy Designation and Priority Review from the FDA. Vera Therapeutics focuses on therapies for serious immunologic diseases, with atacicept as its lead asset in IgA nephropathy. The addition of a Chief Commercial Officer signals that management...

Recent industry attention on eToro Group has focused on how upcoming regulatory changes, including MiFID II amendments, DORA enforcement and a Payment-for-Order-Flow ban, are set to redefine operating standards for digital brokerage platforms. These shifts are expected to raise the bar on transparency, resilience and data connectivity, offering larger players such as eToro an opportunity to deepen user engagement and reinforce trust through stronger compliance and richer account aggregation...

AGNC Investment (NasdaqGS:AGNC) reported robust full-year economic returns for 2025. The company continued its high-yield monthly dividend policy, keeping the payout in double-digit territory. Management outlined a more cautious capital deployment and selective investment approach for 2026. The shift is linked to changing mortgage market conditions, including tighter spreads and prepayment risks. AGNC Investment (NasdaqGS:AGNC) focuses on mortgage backed securities, so shifts in mortgage...

Matson’s latest results and dividend decision Matson (MATX) shares are in focus after the company reported preliminary fourth quarter results that surpassed expectations, supported by stronger freight rates and volumes in its China service. See our latest analysis for Matson. Matson’s strong preliminary fourth quarter update and recent dividend declaration come after a sharp 58.79% 90 day share price return. The 5 year total shareholder return of 166.31% points to longer term compounding,...

Gladstone Land (LAND) is back in focus after confirming continued monthly cash distributions, setting a redemption date of January 30, 2026, for all Series D Preferred Stock, and scheduling its upcoming fourth quarter 2025 earnings release. See our latest analysis for Gladstone Land. The recent announcements on monthly distributions, preferred share redemption and the upcoming earnings release come after a strong run in the stock, with a 30 day share price return of 21.86% and a year to date...

Why VSE (VSEC) Is On Investors’ Radar Today VSE (VSEC) has caught investor attention after a strong recent share price move, with the stock showing solid gains over the month and the past 3 months. This performance has prompted some investors to take a closer look at its fundamentals. See our latest analysis for VSE. That recent momentum sits on top of a longer run, with a 30 day share price return of 26.51% and a very large 5 year total shareholder return of 544.71%. This suggests sentiment...

Lear (NYSE:LEA) has secured General Motors' T1XX program at the Orion plant. The program was previously operated by Magna, with Lear set to begin production in 2027. This award represents a shift in supplier responsibilities on a key GM vehicle program. Lear is a major automotive supplier, best known for seating and electronic systems that go into a wide range of vehicles. Winning the GM T1XX program at Orion from a rival supplier puts fresh attention on how automakers are allocating core...

KLA (KLAC) has just posted Q2 2026 results with revenue of US$3.3 billion and basic EPS of US$8.73, alongside trailing twelve month revenue of US$12.7 billion and EPS of US$34.55 that sit against a 42.1% earnings rise over the past year. Over recent quarters the company has seen revenue move from US$3.1 billion in Q2 2025 to US$3.3 billion in Q2 2026, while quarterly basic EPS shifted from US$6.18 to US$8.73. This sets up the latest report against a backdrop of faster trailing earnings growth...

Waste Management (NYSE:WM) announced a record expansion in operating EBITDA margin and nearly 27% growth in projected free cash flow for 2025. The company approved a 14.5% dividend increase and a new $3 billion share repurchase program. Management highlighted progress on sustainability initiatives, including renewable natural gas facilities and recycling automation projects. With shares of Waste Management trading around $222.24, investors are getting fresh information that goes beyond...

If you are wondering whether Progress Software is attractively priced or not, this article will walk through what the numbers are really saying about its current valuation. The stock closed at US$40.92, with returns of 3.6% decline over 7 days, 4.7% decline over 30 days, 0.4% decline year to date, 28.6% decline over 1 year, 26.2% decline over 3 years, and 1.7% gain over 5 years. This gives you a sense of how sentiment around risk and opportunity has shifted over different timeframes. Recent...

Why Ollie’s recent growth metrics are back in focus Ollie's Bargain Outlet Holdings (OLLI) is drawing fresh attention as investors react to its double-digit annual store growth and steady same-store sales gains. This has raised questions about how the company’s expansion is affecting the current share price. See our latest analysis for Ollie's Bargain Outlet Holdings. At a share price of $110.31, Ollie’s has seen a 2.84% 1 day share price gain. Its 90 day share price return of 8.69% and 1...

Core Scientific (NasdaqGS:CORZ) is shifting its focus from bitcoin mining to high performance computing leasing. The company plans to pursue more HPC colocation contracts starting in 2026. Shareholders recently rejected a proposed merger with CoreWeave, keeping Core Scientific independent. Core Scientific, trading at $17.99, is repositioning itself around HPC leasing while still carrying the legacy of its bitcoin mining roots. The stock has returned 23.6% over the past 30 days and 46.6%...

Astrana Health recently came under pressure after the Centers for Medicare & Medicaid Services proposed only modest payment updates for Medicare Advantage in 2027, raising questions about future revenue tied to these plans. Analysts highlight that Astrana Health’s encounter-driven, risk-adjustment-focused care model could help limit the impact of these proposed policy changes while the company prepares to report its 2025 results in early March 2026. We’ll now look at how the Medicare...

Deckers Outdoor Q3 2026 Earnings Snapshot Deckers Outdoor (DECK) just posted Q3 2026 results with revenue of US$1.96b and basic EPS of US$3.34, supported by net income of US$481.1m as the latest read on the business. The company reported revenue of US$1.83b and EPS of US$3.01 in Q3 2025 compared with US$1.96b and EPS of US$3.34 in Q3 2026, while trailing twelve month EPS sits at US$7.03 on revenue of US$5.37b. With a trailing net margin of 19.3%, these numbers keep profitability at the center...

Insmed recently announced that it will present four abstracts on its treprostinil palmitil inhalation powder (TPIP) program for pulmonary arterial hypertension at the Pulmonary Vascular Research Institute 2026 congress, including Phase 2b topline results and Phase 3 trial design, and it also received new analyst coverage from Barclays. This combination of fresh clinical insight into TPIP and expanded analyst attention highlights how Insmed’s pulmonary pipeline is gaining increased medical...

In recent commentary, analysts highlighted that Driven Brands Holdings' large North American auto service network has been held back by weak same-store sales over the past two years, raising questions about its pricing and marketing approach. An important concern is the company’s history of burning cash and recording negative returns on capital, which has prompted fresh scrutiny of whether its expansive footprint can translate into a sustainable business model. Against this backdrop, we’ll...

International Paper (IP) just wrapped up FY 2025 with Q4 revenue of US$6.0b and a basic EPS loss of US$4.48, as discontinued operations and weaker earnings dragged the bottom line into the red. Over the past year, the company has seen quarterly revenue move from US$4,580m in Q4 2024 to US$6,006m in Q4 2025, while basic EPS shifted from a loss of US$0.42 to a loss of US$4.48, with trailing twelve month EPS at a loss of US$5.61. With the trailing twelve month net income also in loss territory,...

Novavax (NVAX) is back in focus after the company signed a non exclusive License and Option Agreement with Pfizer, giving Pfizer access to its Matrix M adjuvant for vaccines targeting up to two infectious diseases. See our latest analysis for Novavax. The Pfizer agreement comes after a period of renewed interest in Novavax, with a 31.62% 1 month share price return and a 24.05% year to date share price return. However, the 5 year total shareholder return of a 96.95% loss shows that long term...

Forestar Group (FOR) is back in focus after its recent earnings update, where revenue reflected a heavier tilt toward higher priced lot deliveries and western market exposure, while margins stayed under pressure. See our latest analysis for Forestar Group. The recent earnings miss and commentary on softer gross margins came after a sharp pullback around the fourth quarter release. Even so, the 7% year to date share price return and 69.6% three year total shareholder return show that longer...

President Trump’s new executive order curbing institutional purchases of existing single-family homes has put Invitation Homes (INVH) in focus, as investors weigh how limits on acquisitions could affect its single-family rental model. See our latest analysis for Invitation Homes. At a share price of $26.73, Invitation Homes has seen a 1 day share price return of 1.44%. Its 1 year total shareholder return of 10.84% and 3 year total shareholder return of 10.64% point to weaker momentum over a...

Hartford Insurance Group (HIG) just wrapped up FY 2025 with fourth quarter revenue of US$7.3b and basic EPS of US$4.03, alongside net income of US$1.1b that caps off a year of solid headline numbers. Over the past few quarters, the company has seen revenue move from US$6.9b and EPS of US$2.93 in Q4 2024 to US$7.3b and EPS of US$4.03 in Q4 2025, while trailing twelve month revenue reached US$28.4b and EPS came in at US$13.64. With that backdrop, investors are likely to focus on how the margin...